Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials.

Yousif AhmadMahesh V MadhavanGregg W StoneDarrel FrancisRaj MakkarDeepak L BhattJames P Howard

Published in: European heart journal. Quality of care & clinical outcomes (2021)

SGLT-2 inhibitors significantly reduced cardiovascular mortality and heart failure hospitalizations in patients with heart failure. The effect appears consistent across three drugs studied in four trials. SGLT-2 inhibitors should become standard care for patients with heart failure.

Keyphrases

heart failure
healthcare
palliative care
cardiovascular events
atrial fibrillation
left ventricular
quality improvement
cardiovascular disease